Alexis E. Shafii, MD

Dr. Alexis Shafii is a cardiothoracic surgeon with expertise in thoracic transplantation and adult cardiac surgery. Show full bio

His clinical focus includes thoracic organ failure, heart and lung transplantation as well as implantation of mechanical circulatory support devices. He is the surgical director of the heart transplant program at Baylor St. Luke’s Medical Center, and previously directed transplant programs at major medical centers in Dallas and Kentucky.

Dr. Shafii also treats adult acquired cardiac diseases, including coronary artery disease, heart valve disease, and aortic pathologies. His research efforts focus on heart and lung transplantation, ventricular assist devices, and extracorporeal membrane oxygenation (ECMO).

Hide full bio

See Publications

Interests

Heart and Lung Transplant
Cardiac Surgery

Education

Undergraduate:

Boston College
Medical School:

University of South Florida College of Medicine
Residency:

University of South Florida College of Medicine
Fellowships:

Cleveland Clinic Foundation

Certifications

American Board of Surgery
American Board of Thoracic Surgery

Honors, Awards and Memberships

Houstonia Magazine Top Doctor
American College of Surgeons
The International Society for Heart and Lung Transplantation
Society of Thoracic Surgeons
The Texas Heart Institute Academic Professional Staff

Publications

Allen, S. R., Slaughter, M. S., Ahmed, M. M. et al. (2022). COMPETENCE Trial: The EVAHEART 2 continuous flow left ventricular assist device. J Heart Lung Transplant, S1053-2498(22)02180–5. https://doi.org/10.1016/j.healun.2022.10.011.

Inchaustegui, C. A., Patel, A., Lamba, H. K. et al. (2022). Impact of time off anticoagulation in patients with continuous-flow left ventricular assist devices. J Artif Organs. https://doi.org/10.1007/s10047-022-01367-8.

Akkanti, B., Suarez, E. E., O’Neil, E. R. et al. (2022). Extracorporeal membrane oxygenation for COVID-19: Collaborative experience from the Texas Medical Center in Houston with 2 years follow-up. ASAIO J. https://doi.org/10.1097/MAT.0000000000001791.

Chatterjee, S., Loor, G., Shafii, A. E. et al. (2022). Commentary: Get up and go! Pushing the envelope in ambulatory extracorporeal membrane oxygenation. JTCVS Tech 13, 135–136. https://doi.org/10.1016/j.xjtc.2022.04.001.

Lamba, H. K., Parikh, U. M., Vincent, J. et al. (2022). Preoperative hyponatremia and survival after left ventricular assist device implantation. Artif Organs. https://doi.org/10.1111/aor.14280.

Shafii, A., Liao, K. and Ghanta, R. K. (2021). Commentary: Guidance during uncertain times: Navigating the HeartWare HVAD recall. J Thorac Cardiovasc Surg, S0022-5223(21)01710–4. https://doi.org/10.1016/j.jtcvs.2021.12.003.

Loor, G., Chatterjee, S. and Shafii, A. (2021). Extracorporeal membrane oxygenation support before lung transplant: A bridge over troubled water. JTCVS Open 8, 147–154. https://doi.org/10.1016/j.xjon.2021.10.011.

Parikh, U., Lamba, H., Ajmal, M. et al. (2021). Predictors of renal replacement therapy in patients with continuous flow left ventricular assist devices. J Artif Organs 24, 207–216. https://doi.org/10.1007/s10047-020-01239-z.

Lamba, H. K., Kim, M., Santiago, A. et al. (2021). Extracorporeal membrane oxygenation as a bridge to durable left ventricular assist device implantation in INTERMACS-1 patients. J Artif Organs. https://doi.org/10.1007/s10047-021-01275-3.

Galvan, N. T. N., Moreno, N. F., Garza, J. E. et al. (2020). Donor and transplant candidate selection for solid organ transplantation during the COVID-19 pandemic. Am J Transplant 20, 3113–3122. https://doi.org/10.1111/ajt.16138.

Interests

Education

Undergraduate:

Medical School:

Residency:

Fellowships:

Certifications

Honors, Awards and Memberships

Publications

Recent News

The Texas Heart Institute Provides BiVACOR® Total Artificial Heart Patient Update

The Texas Heart Institute Makes a Strong Showing at ISHLT 2023

Sharing Our Latest Research With the World